“…reported that, in comparison with WT monooxygenase P450 BM‐3, variant T235A/R471A/S1024T, obtained from iterative saturation mutagenesis, achieved a 7.9‐fold increase in specific activity in the presence of 2 % (v/v) THF [9] . Many successful enzyme engineering studies were reported to improve OS resistance (e.g., on Candida antarctica lipase B evolution, [10] BSLA‐SSM, [3a, 11] esterase, [12] subtilisin, [13] and protease [14] ) and several protein engineering principles have been proposed, regarding their structural features (e.g., surface region, [11b, 15] access tunnel, [16] binding cleft, [11b, 17] disulfide bridges, [18] and hydrophobic core [16, 18b] ). Multiple recombinations will deepen our understanding of OS resistance and enable general design principles to be systematically studied [11b] .…”